| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |